Table 2.
References (year) | Model design | Inoculum | Outcome | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of animals | Age (weeks) | Weight (kg) | Sex | Breed | Number of wounds | Infection time | Implant/modification | Bacteria | Dose CFU/ml | Volume | Route | Bacterial verification T/I | Infection stage | |
Breuing et al., 2003 | 3 | 24 | 45 | F | Yorkshire | 48 | 2–47 days | Partial thickness (burn) wounds Wound chamber | S. aureus MRSA 25923 | 108 | 1.2 ml | Topical | T: CFU + Histology I: NA | Acute |
Davis et al., 2007 | 6 | NR | 25–35 | F | NR | <279 | 48 h | Partial thickness wounds Wound dressing | S. aureus ATCC 6,538 | 107 | NR | Topical | T: Histology + SEM + EpiM I: NA | Acute |
Hirsch et al., 2008 | 4 | NR | 50–60 | F | Yorkshire (±diabetic) | 56 | 12 days | Full thickness (diabetic) wounds Wound chamber | S. aureus MRSA 25923 | 2 × 108 | NR | Topical | T: CFU + Histology I: NA | Chronic |
Roche et al., 2012 | 40 | NR | 20–25 | F | Yorkshire crossbred | 640–800 | 21 days | Full thickness wounds Wound dressing | S. aureus MRSA ATCC 33592+PJR006 | 1 × 107 1 × 108 | 0.5 or 2 ml | Topical | T: CFU + Histology + SEM I: NA | Chronic |
Nusbaum et al., 2012 | 9 | NR | 35–40 | F | NR | 135 | 23 days | Partial thickness Wound dressing | S. aureus MRSA USA300 | 106 | 25 μl | Topical | T: CFU + Histology I: NA | Chronic |
Davis et al., 2013 | 6 | NR | 40–55 | F | NR | 36 | 21 days | Full thickness wounds Wound dressing | P. aeruginosa 6538 | 500 | NR | Topical | T: PCR + CFU I: NA | Chronic |
T, verification method in tissue; I, verification method on implant; CFU, colony forming units; SEM, scanning electron microscopy; EpiM, epifluorescence microscopy; NR, not registered; F, female. NA, not available.